Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2015

01-07-2015 | Clinical Practice: Clinical Vignettes

Renal Cell Carcinoma Presenting with Paraneoplastic Hallucinations and Cognitive Decline from Limbic Encephalitis

Authors: Joshua W. Harrison, M.D., Ramesh Cherukuri, M.D., Debra Buchan, M.D.

Published in: Journal of General Internal Medicine | Issue 7/2015

Login to get access

ABSTRACT

We present a 66-year-old woman with 2 months of visual hallucinations, unintentional weight loss, and short-term memory decline, whose clinical presentation and EEG supported a diagnosis of limbic encephalitis. Subsequent evaluation for a paraneoplastic etiology revealed a renal mass, which was resected and identified as clear cell renal carcinoma. The patient’s clinical condition improved after resection of the mass. When patients present with incongruous subacute neuropsychiatric symptoms, clinicians should be mindful of paraneoplastic neurological disorders, as early diagnosis and treatment of malignancy may lead to symptomatic improvement.
Literature
1.
go back to reference Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695.PubMedCrossRef Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695.PubMedCrossRef
2.
go back to reference Darnell R, Posner J. Paraneoplastic Syndromes Involving the Nervous System. N Engl J Med. 2003;349:1543–54.PubMedCrossRef Darnell R, Posner J. Paraneoplastic Syndromes Involving the Nervous System. N Engl J Med. 2003;349:1543–54.PubMedCrossRef
3.
go back to reference Vincent A, Buckley C, Schott J, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701–12.PubMedCrossRef Vincent A, Buckley C, Schott J, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701–12.PubMedCrossRef
4.
go back to reference Gultekin S, Rosenfeld M, Voltz R, Eichen J, Posner J, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(7):1481–94.PubMedCrossRef Gultekin S, Rosenfeld M, Voltz R, Eichen J, Posner J, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(7):1481–94.PubMedCrossRef
6.
go back to reference Lawn N, Westmoreland B, Kiely M, Lennon V, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78(11):1363.PubMedCrossRef Lawn N, Westmoreland B, Kiely M, Lennon V, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78(11):1363.PubMedCrossRef
7.
go back to reference Tuzun E, Dalmau J. Limbic Encephalitis and Variants: Classification, Diagnosis, and Treatment. Neurologist. 2007;13:261–71.PubMedCrossRef Tuzun E, Dalmau J. Limbic Encephalitis and Variants: Classification, Diagnosis, and Treatment. Neurologist. 2007;13:261–71.PubMedCrossRef
9.
go back to reference Bell B, Tognoni P, Bihrle R. Limbic encephalitis as a paraneoplastic manifestation of renal cell carcinoma. J Urol. 1998;160:828.PubMedCrossRef Bell B, Tognoni P, Bihrle R. Limbic encephalitis as a paraneoplastic manifestation of renal cell carcinoma. J Urol. 1998;160:828.PubMedCrossRef
10.
go back to reference Kararizou E, Markou I, Zalonis I, et al. Paraneoplastic limbic encephalitis presenting as acute viral encephalitis. J Neurooncol. 2005;75(2):229–32.PubMedCrossRef Kararizou E, Markou I, Zalonis I, et al. Paraneoplastic limbic encephalitis presenting as acute viral encephalitis. J Neurooncol. 2005;75(2):229–32.PubMedCrossRef
11.
go back to reference Titulaer M, Soffietti R, Dalmau J et al. Screening for tumors in paraneoplastic syndromes: report of an EFNS Task Force. Eur J Neurol. 2011; 18(1). Titulaer M, Soffietti R, Dalmau J et al. Screening for tumors in paraneoplastic syndromes: report of an EFNS Task Force. Eur J Neurol. 2011; 18(1).
12.
go back to reference Rosenfeld J, Dalmau. Diagnosis and Management of Paraneoplastic Neurologic Disorders. Neuro-Oncology. 2013;14:528–38. Rosenfeld J, Dalmau. Diagnosis and Management of Paraneoplastic Neurologic Disorders. Neuro-Oncology. 2013;14:528–38.
13.
go back to reference Dalmau J, Gleichman A, Hughes E, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–98.PubMedCentralPubMedCrossRef Dalmau J, Gleichman A, Hughes E, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–98.PubMedCentralPubMedCrossRef
14.
go back to reference Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831–44.PubMedCrossRef Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831–44.PubMedCrossRef
15.
go back to reference Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–48.PubMedCrossRef Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–48.PubMedCrossRef
16.
go back to reference Rosenfeld M, Maarten T, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurology: Clinical Practice. 2012; 215–223. Rosenfeld M, Maarten T, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurology: Clinical Practice. 2012; 215–223.
Metadata
Title
Renal Cell Carcinoma Presenting with Paraneoplastic Hallucinations and Cognitive Decline from Limbic Encephalitis
Authors
Joshua W. Harrison, M.D.
Ramesh Cherukuri, M.D.
Debra Buchan, M.D.
Publication date
01-07-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 7/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-3172-7

Other articles of this Issue 7/2015

Journal of General Internal Medicine 7/2015 Go to the issue

Clinical Practice: Exercises in Clinical Reasoning

A Problematic Palsy: An Exercise in Clinical Reasoning

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.